Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease

被引：4
|
作者：
Bhattacharya, Soumee [1 ]
Montag, Dirk [1 ]
机构：
[1] Leibniz Inst Neurobiol, Neurogenet Special Lab, Magdeburg, Germany
来源：
NEURAL REGENERATION RESEARCH | 2015年 / 10卷 / 01期
关键词：
GALANTAMINE; EFFICACY;
D O I：
10.4103/1673-5374.150648
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：43 / 45
页数：3
相关论文
共 50 条
  • [21] β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease
    Menting, Kelly Willemijn
    Claassen, Jurgen A. H. R.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6 : 1 - 20
  • [22] Cerebral metabolic response to acetylcholinesterase inhibitor treatment in patients with Alzheimer's disease
    Mega, MS
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S70 - S70
  • [23] Role of pyridazine analogs as acetylcholinesterase inhibitor: An approach for management of alzheimer's disease
    Alghamdi, Saad
    Asif, Mohammad
    EURASIAN CHEMICAL COMMUNICATIONS, 2021, 3 (07): : 435 - 442
  • [24] Development of Reminyl® (galantamine), a novel acetylcholinesterase inhibitor, for the treatment of Alzheimer's disease
    Parys, W
    ALZHEIMERS REPORTS, 1998, 1 : S19 - S20
  • [25] Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease
    Wesnes, K.
    Edgar, C.
    Andreasen, N.
    Annas, P.
    Basun, H.
    Lannfelt, L.
    Zetterberg, H.
    Blennow, K.
    Minthon, L.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (04): : 270 - 277
  • [26] Antigonadotropins: A novel strategy to halt Alzheimer's disease progression
    Gregory, CW
    Atwood, CS
    Smith, MA
    Bowen, RL
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (06) : 685 - 690
  • [27] Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease
    Mehta, KM
    Yin, M
    Resendez, C
    Yaffe, K
    NEUROLOGY, 2005, 65 (01) : 159 - 162
  • [28] Acetylcholinesterase inhibition in Alzheimer's disease
    Ibach, B
    Haen, E
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (03) : 231 - 251
  • [29] Molecular basis of successful therapies to delay progression to Alzheimer's disease
    Vina, J.
    Borras, C.
    FEBS OPEN BIO, 2022, 12 : 54 - 54
  • [30] Acetylcholinesterase inhibitors in Alzheimer's disease
    McGleenon, BM
    Dynan, KB
    Passmore, AP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (04) : 471 - 480
12345